References
- Cassorla F, Cianfarani S, Haverkamp F, et al. Growth hormone and treatment outcomes: expert review of current clinical practice. Pediatr Endocrinol Rev 2011;9(2):554-65
- Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85(11):3990-3
- Wilson TA, Rose SR, Cohen P, et al. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143(4):415-21
- Al-Herbish AS, Al-Jurayyan NA, Abobakr AM, et al. Growth hormone: do we have a national perspective of indications for its use? Saudi Med J 2000;21(6):536-8
- Al-Herbish AS. Criteria for diagnosis of growth hormone deficiency: does it exist? Saudi Med J 1999;20(10):766-9
- Bakker B, Frane J, Anhalt H, et al. Height velocity targets from the national cooperative growth study for first-year growth hormone responses in short children. J Clin Endocrinol Metab 2008;93(2):352-7
- Ranke MB, Lindberg A, Chatelain P, et al. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study. J Clin Endocrinol Metab 1999;84(4):1174-83
- Backeljauw P, Bang P, Clayton PE, et al. Diagnosis and management of primary insulin-like growth factor-I deficiency: current perspectives and clinical update. Pediatr Endocrinol Rev 2010;7(Suppl 1):154-71
- Bang P, Bjerknes R, Dahlgren J, et al. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone. Horm Res Paediatr 2011;75(5):335-45
- Valle D, Bartolotta E, Caruso M, et al. Prediction of response to growth hormone treatment in pre-pubertal children with growth hormone deficiency. J Endocrinol Invest 2011;34(6):e126-30
- Carel JC, Butler G. Safety of recombinant human growth hormone. Endocr Dev 2010;18(1):40-54
- Ranke MB, Lindberg A. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables. J Clin Endocrinol Metab 2010;95(3):1229-37
- Jorge AA, Marchisotti FG, Montenegro LR, et al. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 2006;91(3):1076-80
- Cohen P, Germak J, Rogol AD, et al. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab 2010;95(5):2089-98
- Hindmarsh PC, Brook CG. Compliance with growth hormone treatment - is it a problem? Horm Res 1999;51(Suppl 3):104-8